Anti-Biofilm Action of Cineole and to Combat Pneumonia-Causing Drug-Resistant .

Hospital-acquired antibiotic-resistant pneumonia is one of the major causes of mortality around the world that pose a catastrophic threat. is one of the most significant opportunistic pathogens responsible for hospital-acquired pneumonia and gained resistance to the majority of conventional antibiotics. There is an urgent need for antibiotic alternatives to control drug-resistant pneumonia and other related respiratory infections. In the present study, we explored the antibacterial potential of cineole in combination with homeopathic medicines against biofilm-forming drug-resistant . Out of 26 selected and screened homeopathic medicines, (HyPer) was found to eradicate biofilm-forming drug-resistant most effectively when used in combination with cineole. Interestingly, the synergistic action of HyPer and cineole was also found to be similarly effective against planktonic cells of . Further, the potential synergistic killing mechanisms of cineole and HyPer were determined by analyzing zeta membrane potential, outer membrane permeability, and DNA release from cells upon treatment with cineole and HyPer. Additionally, molecular docking analysis revealed strong binding affinities of hypericin (an active ingredient of HyPer) with the PqsA (a quorum sensing protein) of . Overall, our findings revealed the potential synergistic action of cineole and HyPer against biofilm-forming drug-resistant . Cineole and HyPer could be used in combination with other bronchodilators as inhalers to control the biofilm-forming drug-resistant .